News

Laurus Labs has allotted 3,93,001 equity shares under ESOP on 04 June 2026. The total paid up capital of the Company after the above allotments stands at Rs.1,08,04,99,166/- divided into 54,02,49,583 equity shares of Rs.2/- each.

Net profit of Laurus Labs rose 19.46% to Rs 279.14 crore in the quarter ended March 2026 as against Rs 233.67 crore during the previous quarter ended March 2025. Sales rose 5.31% to Rs 1811.57 crore in the quarter ended March 2026 as against Rs 1720.30 crore during the previous quarter ended March 2025.For the full year,net profit rose 148.04% to Rs 888.79 crore in the year ended March 2026 as against Rs 358.32 crore during the previous year ended March 2025. Sales rose 22.67% to Rs 6812.90 crore in the year ended March 2026 as against Rs 5553.96 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1811.571720.30 5 6812.905553.96 23 OPM %28.2724.45 -26.0919.00 - PBDT483.47422.77 14 1661.93914.38 82 PBT361.37312.34 16 1181.88484.29 144 NP279.14233.67 19 888.79358.32 148 Powered by Capital Market - Live News

Laurus Labs announced that the 21th Annual General Meeting(AGM) of the company will be held on 2 July 2026.

Laurus Labs announced that the Board of Directors of the Company at its meeting held on 30 April 2026, inter alia, have recommended the Second Interim dividend of Rs 1.2 per equity Share (i.e. 60%) , subject to the approval of the shareholders.

Laurus Labs will hold a meeting of the Board of Directors of the Company on 30 April 2026.